Mobile imaging provider American Shared Hospital Services of San Francisco reported June 1 that the Federal Trade Commission has requested additional information about the company's intended sale of its medical imaging assets to Alliance Imaging.
Mobile imaging provider American Shared Hospital Services of San Francisco reported June 1 that the Federal Trade Commission has requested additional information about the company's intended sale of its medical imaging assets to Alliance Imaging. American Shared declined to comment on the nature of the FTC's request, or to say whether it would delay the close of the transaction, anticipated for the third quarter of 1998.
Industry watchers question whether the request arises out of Alliance's aggressive acquisitions of other mobile imaging companies, which has made the Anaheim, CA-based imaging services provider by far the largest player in the mobile market. Alliance recently acquired Mobile Technology of Los Angeles for an estimated $100 million, and now runs 180 mobile MRI systems throughout the U.S.
Alliance announced March 12 its intent to purchase American Shared's mobile routes for $13.6 million, and agreed to assume the company's $26.1 million debt (SCAN 3/18/98). American Shared is one of the largest remaining independent mobile companies, with 30 MRI and 15 CT routes across the U.S.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
2 Commerce Drive
Cranbury, NJ 08512